Authors:
Kiran Pulidindi, Kunal Ahuja
Download free PDF
Nutricosmetic Ingredients Market Size & Share 2026-2035
Report ID: GMI13764
|
Published Date: November 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Nutricosmetic Ingredients Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Nutricosmetic Ingredients Market Size
The Nutricosmetic Ingredients Market was valued at USD 4.20 billion in 2025 and is projected to reach USD 4.50 billion in 2026, growing at a 7.2% CAGR from 2026 to 2035, when it is forecast to reach USD 8.44 billion.
Nutricosmetic Ingredients Market Key Takeaways
Market Leader: dsm-firmenich led with over 14% market share in 2025.
Leading Players: Top 5 players in this market include dsm-firmenich, BASF SE, Rousselot, GELITA AG, Lonza Group, which collectively held a market share of 47% in 2025.
The nutricosmetic ingredients market covers the B2B supply of bioactive inputs to manufacturers of ingestible and dual-purpose beauty products, rather than sales of finished consumer goods. Its expansion reflects the convergence of clinical nutrition and premium personal care, with brand owners increasingly prioritizing traceable, clinically documented actives that can support differentiated formulation and claim strategies.
GMI Analyst View
Based on primary research conducted with ingredient manufacturers, contract formulators, and global brand owners, the nutricosmetic ingredients market generated USD 3.90 billion in 2024. We view the category's transition into mainstream supplement, pharmacy, and digital channels as a procurement inflection point: evidence-backed actives are becoming an established personal care delivery system rather than a niche wellness adjunct.
Nutricosmetic Ingredients Market Trends, Growth Drivers & GMI Forecast Outlook
Demand is moving toward ingredients that can combine a credible biological mechanism with stable sourcing, formulation compatibility, and a usable substantiation file. This favors suppliers able to support beauty-from-within launches across supplements, beverages, and hybrid routines while managing the evidence and supply-chain burden attached to premium actives.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Population aging expands the addressable market, but its purchasing effects differ by cohort and channel. Mature markets concentrate demand around clinically positioned healthy-aging products, whereas preventive-aging consumers in emerging economies are widening the opportunity for accessible beauty supplements. In both cases, suppliers with evidence packages for skin hydration, elasticity, barrier support, or hair and nail outcomes are better positioned to convert consumer interest into recurring brand-owner procurement.
Collagen is being reclassified commercially from a largely specification-led input to a performance-tier active. The important shift is not simply broader collagen use, but the increasing value assigned to supplier-owned clinical dossiers, identifiable peptide profiles, traceability, and formulation support. Those attributes allow brands to build more defensible claims and support longer procurement relationships than are typical for interchangeable protein ingredients.
European regulatory clarity also improves the planning horizon for active-ingredient development. When formulation teams can assess permitted specifications earlier in product development, they can more confidently invest in stability work, sensory optimization, packaging, and channel-specific launches. This particularly benefits ingredients that bridge dietary supplements and functional foods, where reformulation cycles are more operationally demanding.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Marine-origin risk reaches beyond occasional input-price movements. Fisheries-based sourcing can expose collagen and omega ingredient buyers to quota decisions, certification requirements, geographic concentration, and competing uses for feedstock. As a result, traceability is becoming a commercial requirement as well as a sustainability consideration, and fermentation-based hyaluronic acid, algae-derived lipids, and plant-origin alternatives are gaining strategic relevance.
Collagen-market consolidation can alter the negotiating position of smaller formulators, especially those relying on short-cycle purchasing rather than contracted supply. Scale suppliers can offer global production, application support, and clinical assets, but concentrated procurement can make buyer diversification harder. That tension encourages brands to protect supply continuity through multiple approved sources, alternative formats, and more deliberate inventory planning.
Claim substantiation is also shaping the category's innovation economics. New active ingredients must carry the cost of human evidence, ingredient characterization, and documentation that can be transferred into a brand's compliance process. Suppliers that cannot support this work may still compete in price-sensitive formulations, but they face a weaker position in premium products where evidence is a core part of the commercial proposition.
GMI Analyst View
We see the principal competitive divide forming between documented specialty actives and undifferentiated commodity inputs. Suppliers that combine clinical substantiation, traceable sourcing, and application support can protect their strategic relevance, while companies competing principally on input price face pressure from both claim scrutiny and supply-chain concentration.
Nutricosmetic Ingredients Market Segment Analysis
By Ingredient Type
Collagen and peptides generated USD 1.09 billion in 2025 and are forecast to reach USD 2.27 billion by 2035. The nutricosmetic ingredients market relies on this category for skin elasticity, hydration, and structural-support positioning across powders, sachets, capsules, and beverages. Clinical documentation, molecular profile consistency, source traceability, and solubility determine whether suppliers participate in premium contracted programs or in price-led commodity purchasing.
Vitamins and minerals are projected to reach USD 1.49 billion by 2035, after representing 19.0% of market revenue in 2025. Their broad use makes them foundational formulation components rather than standalone differentiation tools. Premium demand is shifting toward bioavailable forms, botanical complexes, and combination systems that enable brands to pair familiar nutritional ingredients with specialty actives in targeted skin, hair, and nail propositions.
Carotenoids generated USD 462 million in 2025 and are expected to expand at a 7.0% CAGR from 2026 to 2035. Astaxanthin, lycopene, lutein, zeaxanthin, and beta-carotene serve photoprotection and antioxidant-oriented product concepts. Suppliers with algae-derived, standardized, and regulatory-ready formats are positioned to benefit as formulators seek ingredients that fit clean-label and evidence-led beauty narratives.
Omega fatty acids are projected to reach USD 752 million by 2035 and are expected to grow at a 6.0% CAGR from 2026 to 2035. Standard fish-oil formats remain exposed to commoditization and marine sourcing concerns, while algal DHA and EPA, as well as specialty botanical lipid systems, offer more differentiated routes into vegan, traceable, and skin-barrier-oriented products.
Probiotics and prebiotics are projected to reach USD 855 million by 2035 and are expected to grow at an 8.5% CAGR from 2026 to 2035. The segment is gaining importance as formulators connect microbiome positioning with skin hydration, barrier function, and broader wellness outcomes. Strain identity, viability through processing, dosage stability, and relevant clinical substantiation are central to supplier qualification.
Polyphenols and flavonoids generated USD 336 million in 2025 and are forecast to reach USD 673 million by 2035. Their appeal lies in antioxidant, longevity, and photoprotection positioning, particularly in blends that combine botanical extracts with conventional beauty-support nutrients. Consistency of phytochemical content and transparency around botanical sourcing are increasingly important for suppliers serving premium programs.
Hyaluronic acid accounted for 6.0% of market revenue in 2025 and is projected to reach USD 544 million by 2035. Oral hydration and dermal-density applications are supporting demand, while biofermentation-derived grades are strengthening their position through consistent purity, scalable production, and a clean-label sourcing narrative. Regulatory clarity for food-supplement applications further reduces formulation friction in key markets.
By End-Use Product Category
Dietary supplements generated USD 2.39 billion in 2025 and are expected to account for 54.8% of revenue by 2035. Capsules, softgels, powders, and sachets remain the principal delivery formats for concentrated actives. This channel rewards suppliers that can meet high-volume specifications reliably while offering tiered evidence, documentation, and certification support for differentiated brand portfolios.
Functional beverages are projected to reach USD 1.63 billion by 2035 and are expected to grow at an 8.0% CAGR from 2026 to 2035. Ready-to-drink beauty formats place distinctive demands on ingredient solubility, flavor compatibility, heat tolerance, and shelf-life performance. Suppliers that can address those constraints are better placed to participate in premium convenience-led launches.
Functional food and snacks represented 13.0% of market revenue in 2025 and are forecast to reach USD 1.07 billion by 2035. Fortified dairy alternatives, bars, confectionery, broths, and cereals allow brands to embed beauty positioning in established food occasions. Ingredient suppliers must balance efficacy-linked doses with sensory performance, processing resilience, and label simplicity.
Topical-ingestible combinations generated USD 294 million in 2025 and are expected to grow at a 9.0% CAGR from 2026 to 2035. Coordinated oral and topical routines create an opportunity for suppliers that can support aligned active selection, dual-format technical performance, and coherent evidence strategies. The format's complexity also raises qualification barriers and supports differentiated supplier positioning.
Oral and dental care is projected to reach USD 190 million by 2035 and is expected to expand at an 8.5% CAGR from 2026 to 2035. Probiotic strains, minerals, and other oral-health-support ingredients are moving beyond conventional supplement positioning as consumers increasingly connect oral microbiome health with broader wellness. This creates an emerging specialty channel with distinct regulatory and formulation requirements.
GMI Analyst View
We believe the strongest segment opportunities sit where formulation complexity creates a meaningful barrier to entry. Suppliers that solve stability, bioavailability, sensory, and documentation challenges for beverages, microbiome systems, and coordinated oral-topical routines should command greater strategic value than providers limited to interchangeable bulk inputs.
Nutricosmetic Ingredients Market Regional Analysis
North America Nutricosmetic Ingredients Market Analysis
North America generated USD 1.21 billion in 2025 and is projected to reach USD 2.35 billion by 2035. The Nutricosmetic Ingredients Market in the region is supported by established supplement retail, direct-to-consumer brand activity, and strong demand for clinically supported premium formats. Procurement is increasingly shaped by the ability of suppliers to provide compliant documentation, reliable quality systems, and application support for functional beverages and combination products.
United States
The United States generated USD 1.05 billion in 2025 and is projected to reach USD 2.02 billion by 2035. A large specialty retail, pharmacy, wellness, and digital commerce ecosystem supports a diverse buyer base, while the emphasis on substantiation encourages brands to favor clinically documented inputs. This gives suppliers with evidence-transfer capabilities an advantage in premium beauty-from-within formulations.
Europe Nutricosmetic Ingredients Market Analysis
Europe represented 24.0% of global revenue in 2025 and is projected to reach USD 1.85 billion by 2035. Mature supplement markets, clean-beauty preferences, and demanding food-safety requirements favor authorized, well-documented actives. The region's regulatory environment can extend product-development work, but it also provides a quality screen that supports differentiated suppliers with established compliance capabilities.
Germany
Germany accounted for 4.5% of global revenue in 2025 and is projected to reach USD 337 million by 2035. Its role as both a premium end market and a central European manufacturing and distribution hub supports demand for certified collagen, vitamin, and botanical inputs. Buyers place particular value on auditability, specification consistency, and established technical support.
Asia Pacific Nutricosmetic Ingredients Market Analysis
Asia Pacific generated USD 1.51 billion in 2025 and is expected to account for 38.0% of revenue by 2035. The Nutricosmetic Ingredients Market benefits from Japan's functional-food heritage, South Korea's ingestible beauty culture, China's scale in premium beauty supplements, and expanding nutraceutical retail across South and Southeast Asia. Regional demand favors formats that combine convenience, visible beauty relevance, and clear ingredient provenance.
China
China represented 13.0% of global revenue in 2025 and is projected to grow at an 8.2% CAGR from 2026 to 2035. Domestic digital channels and premiumization are expanding demand for traceable collagen, hydration-oriented actives, and locally relevant product concepts. Suppliers need strong labeling, regulatory, and channel-adaptation capabilities to translate global ingredient platforms into locally credible propositions.
Latin America Nutricosmetic Ingredients Market Analysis
Latin America is projected to reach USD 505 million by 2035, after accounting for 6.0% of global revenue in 2025. The region is benefiting from broader pharmacy, specialty-retail, and e-commerce distribution for wellness products. As beauty-from-within concepts become more accessible, brands are seeking ingredients that can support familiar benefits at commercially viable cost points.
Brazil
Brazil generated USD 168 million in 2025 and is projected to reach USD 337 million by 2035. Its established engagement with beauty, aesthetic wellness, and supplements underpins demand for collagen, vitamins, carotenoids, and other familiar beauty-support inputs. Suppliers that can combine regulatory readiness with locally relevant commercial support are well placed as the market broadens beyond early premium adopters.
Middle East & Africa Nutricosmetic Ingredients Market Analysis
Middle East & Africa generated USD 210 million in 2025 and is expected to grow at a 9.7% CAGR from 2026 to 2035. The Nutricosmetic Ingredients Market is being supported by premium wellness spending in the Gulf, broader pharmacy and digital retail access, and a rising focus on preventive health. Growth is occurring from a relatively lower procurement base, creating opportunities for suppliers that establish local distribution and regulatory capabilities early.
Saudi Arabia
Saudi Arabia is projected to reach USD 253 million by 2035 and is expected to grow at a 10.2% CAGR from 2026 to 2035. Preventive-health investment, premium consumer preferences, and expanding specialty retail are creating a receptive market for differentiated ingestible beauty formats. Suppliers able to support authorized claims, premium positioning, and dependable regional supply will be best positioned to capture this growth.
GMI Analyst View
We view Asia Pacific and the Gulf markets as strategically important growth arenas, but they require different operating models. Scale-oriented markets reward localization and distribution depth, while premium Gulf channels reward brand prestige, authorized claims, and differentiated ingredient stories. A uniform regional strategy is unlikely to capture both opportunities effectively.
Nutricosmetic Ingredients Market Share & Competitive Landscape
The nutricosmetic ingredients market share structure is moderately to highly concentrated at the upper tier, where the five largest suppliers held approximately 47% of the market in 2025. Large integrated suppliers compete through clinical substantiation, global production networks, application expertise, portfolio breadth, and established customer qualification systems, while regional specialists retain relevance in botanicals, fermentation-derived actives, and focused delivery technologies.
dsm-firmenich held approximately 14% of market share in 2025. Its position reflects a broad portfolio across vitamins, carotenoids, omega ingredients, probiotics, and specialty actives, supported by formulation and delivery-system capabilities. The company's competitive advantage lies in its ability to serve multiple end-use formats while pairing ingredients with technical and commercial support.
BASF SE held approximately 12% of market share in 2025. Its vitamins and carotenoids platform provides scale in high-volume procurement, while its scientific and regulatory resources support participation in more differentiated functional-active programs. The company is particularly well placed where brand owners seek dependable quality systems alongside large-scale supply.
Rousselot held approximately 8% of market share in 2025. Its collagen and peptide franchise is reinforced by branded ingredient platforms, clinical substantiation, and global production reach. The company is positioned to benefit as buyers seek performance-oriented collagen systems rather than undifferentiated protein supply.
GELITA and Lonza occupy influential positions in specialty collagen, peptide, delivery, and active-ingredient systems. GELITA's branded peptide platforms support targeted beauty and wellness applications, while Lonza's formulation and delivery capabilities complement its specialty active portfolio. Both illustrate the importance of combining ingredient performance with technical services that reduce development risk for brands.
The broader competitive field includes Evonik Industries, Kerry Group, ADM, Lycored, Givaudan including Naturex, Novonesis, Croda International, Gnosis by Lesaffre, Mibelle Biochemistry, and Nexira. These suppliers compete through focused capabilities in amino acids, probiotics, algal oils, carotenoids, botanical extracts, fermentation, specialty lipids, vitamins, plant-derived actives, and prebiotic systems. Competitive intensity is increasing as brands demand stronger documentation, more transparent sourcing, and format-specific application support.
Nutricosmetic Ingredients Market Recent Industry Developments
Darling Ingredients & Tessenderlo Group — Joint Venture Agreement, December 2025
Darling Ingredients and Tessenderlo Group advanced plans to combine the Rousselot and PB Leiner collagen and gelatin businesses under Nextida, subject to customary approvals [5]Darling Ingredients Inc. "Darling Ingredients and Tessenderlo Group Agree to Form New Company to Accelerate Growth in Attractive Collagen-Based Health, Wellness and Nutrition Sector." darlingii.com. The proposed combination would bring together complementary production footprints, clinical-development assets, and branded collagen platforms, further underscoring the strategic value of supply scale and evidence-backed peptide offerings.
dsm-firmenich — Strategic Partnership with Inscripta, April 2025
dsm-firmenich announced a strategic partnership with Inscripta to develop biotech-derived well-aging skincare actives [6]dsm-firmenich AG. "dsm-firmenich and Inscripta Announce Strategic Partnership to Drive Biotech Innovations in Well-Aging Skincare." dsm-firmenich.com. The collaboration highlights growing interest in precision fermentation and engineered microbial platforms as potential routes to differentiated beauty ingredients with less dependence on conventional marine and botanical feedstocks.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →